Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miki Katoh

Showing results (1-10 of 79) with videos related to

Pageof 8
Sort By:
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|October 2, 2015
[Effects of Xenobiotics on Drug Pharmacokinetics and Safety]Miki Katoh
Drug Metabolism Reviews|March 17, 2007
Application of chimeric mice with humanized liver for predictive ADMEMiki Katoh, Tsuyoshi Yokoi
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 17, 2013
[Changes in pharmacokinetics in elderly patients]Masayuki Nadai, Miki Katoh
Biological & Pharmaceutical Bulletin|April 4, 2022
The Effect of Single-Walled Carbon Nanotubes on UDP-Glucuronosyltransferase 1A Activity in Human LiverYuki Asai, Masayuki Nadai, Miki Katoh
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|March 21, 2022
Species and tissue differences in regorafenib glucuronidationAyaka Kojima, Masayuki Nadai, Miki Katoh
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 16, 2007
Glucuronidation of antiallergic drug, Tranilast: identification of human UDP-glucuronosyltransferase isoforms and effect of its phase I metaboliteMiki Katoh, Tomohito Matsui, Tsuyoshi Yokoi
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|November 4, 2015
Species and tissue differences in serotonin glucuronidationYukiko Sakakibara, Miki Katoh, Taisho Kawayanagi, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 20, 2015
Effects of Phenobarbital on Expression of UDP-Glucuronosyltransferase 1a6 and 1a7 in Rat BrainYukiko Sakakibara, Miki Katoh, Yuya Kondo, et al.
Drug Metabolism and Pharmacokinetics|February 9, 2025
Substrate inhibition potential of arachidonic acid on 14,15-epoxidation, a biological drug developmental target, mediated by recombinant human cytochrome P450 2J2 and 2C8 enzymesAyaka Kojima, Masayuki Nadai, Hiroshi Yamazaki, et al.
Toxicology|February 6, 2008
Chimeric mice with humanized liverMiki Katoh, Chise Tateno, Katsutoshi Yoshizato, et al.
Pageof 8

Showing results (1-10 of 79) with videos related to

Sort By:
Pageof 8
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|October 2, 2015
[Effects of Xenobiotics on Drug Pharmacokinetics and Safety]Miki Katoh
Drug Metabolism Reviews|March 17, 2007
Application of chimeric mice with humanized liver for predictive ADMEMiki Katoh, Tsuyoshi Yokoi
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 17, 2013
[Changes in pharmacokinetics in elderly patients]Masayuki Nadai, Miki Katoh
Biological & Pharmaceutical Bulletin|April 4, 2022
The Effect of Single-Walled Carbon Nanotubes on UDP-Glucuronosyltransferase 1A Activity in Human LiverYuki Asai, Masayuki Nadai, Miki Katoh
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|March 21, 2022
Species and tissue differences in regorafenib glucuronidationAyaka Kojima, Masayuki Nadai, Miki Katoh
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 16, 2007
Glucuronidation of antiallergic drug, Tranilast: identification of human UDP-glucuronosyltransferase isoforms and effect of its phase I metaboliteMiki Katoh, Tomohito Matsui, Tsuyoshi Yokoi
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|November 4, 2015
Species and tissue differences in serotonin glucuronidationYukiko Sakakibara, Miki Katoh, Taisho Kawayanagi, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 20, 2015
Effects of Phenobarbital on Expression of UDP-Glucuronosyltransferase 1a6 and 1a7 in Rat BrainYukiko Sakakibara, Miki Katoh, Yuya Kondo, et al.
Drug Metabolism and Pharmacokinetics|February 9, 2025
Substrate inhibition potential of arachidonic acid on 14,15-epoxidation, a biological drug developmental target, mediated by recombinant human cytochrome P450 2J2 and 2C8 enzymesAyaka Kojima, Masayuki Nadai, Hiroshi Yamazaki, et al.
Toxicology|February 6, 2008
Chimeric mice with humanized liverMiki Katoh, Chise Tateno, Katsutoshi Yoshizato, et al.
Pageof 8